Correlation Between Virax Biolabs and EnGene Holdings

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Virax Biolabs and EnGene Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Virax Biolabs and EnGene Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Virax Biolabs Group and enGene Holdings Common, you can compare the effects of market volatilities on Virax Biolabs and EnGene Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Virax Biolabs with a short position of EnGene Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of Virax Biolabs and EnGene Holdings.

Diversification Opportunities for Virax Biolabs and EnGene Holdings

-0.46
  Correlation Coefficient

Very good diversification

The 3 months correlation between Virax and EnGene is -0.46. Overlapping area represents the amount of risk that can be diversified away by holding Virax Biolabs Group and enGene Holdings Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on enGene Holdings Common and Virax Biolabs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Virax Biolabs Group are associated (or correlated) with EnGene Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of enGene Holdings Common has no effect on the direction of Virax Biolabs i.e., Virax Biolabs and EnGene Holdings go up and down completely randomly.

Pair Corralation between Virax Biolabs and EnGene Holdings

Given the investment horizon of 90 days Virax Biolabs Group is expected to generate 3.94 times more return on investment than EnGene Holdings. However, Virax Biolabs is 3.94 times more volatile than enGene Holdings Common. It trades about 0.1 of its potential returns per unit of risk. enGene Holdings Common is currently generating about -0.21 per unit of risk. If you would invest  168.00  in Virax Biolabs Group on August 23, 2024 and sell it today you would earn a total of  26.00  from holding Virax Biolabs Group or generate 15.48% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Virax Biolabs Group  vs.  enGene Holdings Common

 Performance 
       Timeline  
Virax Biolabs Group 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Virax Biolabs Group has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
enGene Holdings Common 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in enGene Holdings Common are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating technical and fundamental indicators, EnGene Holdings displayed solid returns over the last few months and may actually be approaching a breakup point.

Virax Biolabs and EnGene Holdings Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Virax Biolabs and EnGene Holdings

The main advantage of trading using opposite Virax Biolabs and EnGene Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Virax Biolabs position performs unexpectedly, EnGene Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in EnGene Holdings will offset losses from the drop in EnGene Holdings' long position.
The idea behind Virax Biolabs Group and enGene Holdings Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.

Other Complementary Tools

Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Bonds Directory
Find actively traded corporate debentures issued by US companies
Transaction History
View history of all your transactions and understand their impact on performance
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments